These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 35615952)

  • 1. Characterization of healthcare-associated infections with the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) omicron variant at a tertiary healthcare center.
    Holowka T; DiBiase LM; Sickbert-Bennett E; Teal LJ; Weber DJ
    Infect Control Hosp Epidemiol; 2023 Jan; 44(1):133-135. PubMed ID: 35615952
    [No Abstract]   [Full Text] [Related]  

  • 2. Incidence and outcomes of hospital-associated coronavirus disease 2019 (COVID-19) before and after emergence of the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) omicron variant.
    Williams VR; Tan C; Kozak R; Leis JA
    Infect Control Hosp Epidemiol; 2023 Oct; 44(10):1698-1700. PubMed ID: 36876324
    [No Abstract]   [Full Text] [Related]  

  • 3. Lack of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) transmission from a healthcare worker to a cohort of immunosuppressed patients during the SARS-CoV-2 omicron variant surge, California, 2022.
    Karan A; Ferguson J; Salinas JL
    Infect Control Hosp Epidemiol; 2023 Jan; 44(1):156-157. PubMed ID: 35794737
    [No Abstract]   [Full Text] [Related]  

  • 4. Discontinuation of admission screening for coronavirus disease 2019 (COVID-19) and the impact on in-hospital clusters of COVID-19: Experience at a tertiary-care center.
    Honda H; Nakagawa M; Nisida R; Shintani C; Hamagishi M; Uehara Y; Iwata M; Doi Y
    Infect Control Hosp Epidemiol; 2023 Nov; 44(11):1877-1880. PubMed ID: 37088552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the COVID-19 pandemic on healthcare-associated viral respiratory infections at a tertiary care pediatric hospital.
    Lefebvre MA; Rajda E; Frenette C; Paquet F; Rubin E; Sleno H; Stachura M; Tse W; Salvadori MI
    Am J Infect Control; 2023 Aug; 51(8):961-963. PubMed ID: 36736901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant in Patients with Philadelphia-Negative Myeloproliferative Neoplasm: A Single Center Experience.
    Ali EAH; Khamees I; Alshurafa A; Qasim H; Abu-Tineh MA; Ahmed K; Saad E; Yassin M
    Oncology; 2022; 100(8):460-466. PubMed ID: 35882185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duration of Infectious Virus Shedding by SARS-CoV-2 Omicron Variant-Infected Vaccinees.
    Takahashi K; Ishikane M; Ujiie M; Iwamoto N; Okumura N; Sato T; Nagashima M; Moriya A; Suzuki M; Hojo M; Kanno T; Saito S; Miyamoto S; Ainai A; Tobiume M; Arashiro T; Fujimoto T; Saito T; Yamato M; Suzuki T; Ohmagari N
    Emerg Infect Dis; 2022 May; 28(5):998-1001. PubMed ID: 35290176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of universal admission testing for severe acute respiratory coronavirus 2 (SARS-CoV-2) in era of the omicron variant.
    Williams VR; Chan CK; Chan AK; Kozak R; Leis JA
    Infect Control Hosp Epidemiol; 2023 Jan; 44(1):102-105. PubMed ID: 36651289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between immunity and viral shedding duration in non-severe SARS-CoV-2 Omicron variant-infected patients.
    He S; Fang Y; Yang J; Wang W
    Front Public Health; 2022; 10():1032957. PubMed ID: 36620263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two Cases of Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infections Caused by the Omicron Variant (B.1.1.529 Lineage) in International Travelers to Japan.
    Maruki T; Iwamoto N; Kanda K; Okumura N; Yamada G; Ishikane M; Ujiie M; Saito M; Fujimoto T; Kageyama T; Saito T; Saito S; Suzuki T; Ohmagari N
    Clin Infect Dis; 2022 Aug; 75(1):e354-e356. PubMed ID: 34979547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infection with SARS-CoV-2 Omicron Variant 24 Days after Non-Omicron Infection, Pennsylvania, USA.
    Seid AG; Yirko T; Sayeed S; Plipat N
    Emerg Infect Dis; 2022 Sep; 28(9):1911-1913. PubMed ID: 35914519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical efficacy and in vitro neutralization capacity of monoclonal antibodies for severe acute respiratory syndrome coronavirus 2 delta and omicron variants.
    Brehm TT; Pfefferle S; von Possel R; Karolyi M; Zoufaly A; Wichmann D; Kobbe R; Emmerich P; Nörz D; Aepfelbacher M; Schulze Zur Wiesch J; Addo MM; Schmiedel S; Lütgehetmann M
    J Med Virol; 2022 Oct; 94(10):5038-5043. PubMed ID: 35662058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 Infection With the Omicron SARS-CoV-2 Variant in a Cohort of Kidney and Kidney Pancreas Transplant Recipients: Clinical Features, Risk Factors, and Outcomes.
    Wong G; Rowlandson M; Sabanayagam D; Ginn AN; Kable K; Sciberras F; Au E; Draper J; Arnott A; Sintchenko V; Dwyer DE; Chen SCA; Kok J
    Transplantation; 2022 Sep; 106(9):1860-1866. PubMed ID: 35675438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Community Transmission of SARS-CoV-2 Omicron Variant, South Korea, 2021.
    Kim EY; Choe YJ; Park H; Jeong H; Chung JH; Yu J; Ko HP; Ahn HJ; Go MY; Lee JH; Kim WI; Lee BS; Kim S; Yu M; Kim J; Lee HR; Jang EJ; Lee JJ; Lee HY; Kim JM; Choi JH; Lee SE; Kim IH; Park AK; Rhee JE; Kim EJ; Lee S; Park YJ
    Emerg Infect Dis; 2022 Apr; 28(4):898-900. PubMed ID: 35171760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expansion of L452R-Positive SARS-CoV-2 Omicron Variant, Northern Lombardy, Italy.
    Novazzi F; Baj A; Genoni A; Focosi D; Maggi F
    Emerg Infect Dis; 2022 Jun; 28(6):1301-1302. PubMed ID: 35416767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transmission of severe acute respiratory coronavirus virus 2 (SARS-CoV-2), delta variant, between two fully vaccinated healthcare personnel.
    Smith LL; Milstone AM; Jibowu M; Luo CH; Morris CP; Mostafa HH; Maragakis LL
    Infect Control Hosp Epidemiol; 2022 Dec; 43(12):1983-1985. PubMed ID: 34743764
    [No Abstract]   [Full Text] [Related]  

  • 17. SARS-CoV-2 nosocomial infection: Real-world results of environmental surface testing from a large tertiary cancer center.
    Shah MR; Jan I; Johns J; Singh K; Kumar P; Belarmino N; Saggiomo KJ; Hayes C; Washington K; Toppmeyer DL; Haffty BG; Libutti SK; Evens AM
    Cancer; 2021 Jun; 127(11):1926-1932. PubMed ID: 33599303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural Study of SARS-CoV-2 Antibodies Identifies a Broad-Spectrum Antibody That Neutralizes the Omicron Variant by Disassembling the Spike Trimer.
    Zhan W; Tian X; Zhang X; Xing S; Song W; Liu Q; Hao A; Hu Y; Zhang M; Ying T; Chen Z; Lan F; Sun L
    J Virol; 2022 Aug; 96(16):e0048022. PubMed ID: 35924918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probable Transmission of SARS-CoV-2 Omicron Variant in Quarantine Hotel, Hong Kong, China, November 2021.
    Gu H; Krishnan P; Ng DYM; Chang LDJ; Liu GYZ; Cheng SSM; Hui MMY; Fan MCY; Wan JHL; Lau LHK; Cowling BJ; Peiris M; Poon LLM
    Emerg Infect Dis; 2022 Feb; 28(2):460-462. PubMed ID: 34860154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental Infection of Mink with SARS-COV-2 Omicron Variant and Subsequent Clinical Disease.
    Virtanen J; Aaltonen K; Kegler K; Venkat V; Niamsap T; Kareinen L; Malmgren R; Kivelä O; Atanasova N; Österlund P; Smura T; Sukura A; Strandin T; Dutra L; Vapalahti O; Nordgren H; Kant R; Sironen T
    Emerg Infect Dis; 2022 Jun; 28(6):1286-1288. PubMed ID: 35608951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.